Loading…
Cue Biopharma, Inc. is projected to decline to $34.46 by 2027, a -6% move from its current price of $36.78. CUE is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/11/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 12 | $34.29 | $36.78 | $39.46 | +0.01% |
| Jul 13 | $33.30 | $36.79 | $40.63 | +0.02% |
| Jul 14 | $32.57 | $36.79 | $41.55 | +0.03% |
| Jul 15 | $31.97 | $36.79 | $42.35 | +0.03% |
| Jul 16 | $31.44 | $36.80 | $43.06 | +0.04% |
| Jul 17 | $30.98 | $36.80 | $43.72 | +0.05% |
| Jul 18 | $30.55 | $36.80 | $44.33 | +0.06% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $30.55 | $36.80 | $44.33 | +0.06% |
| Week 2 | $28.31 | $36.82 | $47.91 | +0.12% |
| Week 3 | $26.70 | $36.85 | $50.85 | +0.18% |
| Week 4 | $25.41 | $36.87 | $53.49 | +0.24% |
| Week 5 | $24.34 | $36.89 | $55.92 | +0.30% |
| Week 6 | $23.40 | $36.91 | $58.22 | +0.36% |
| Week 7 | $22.58 | $36.93 | $60.42 | +0.42% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Cue Biopharma, Inc. is a clinical-stage therapeutics company focused on developing therapies for immunological disorders. The company’s lead asset is CUE-221, an anti-IgE antibody with a dual-mechanism of action currently in Phase 2 development for allergic diseases.
It also developed the Immuno-STAT platform, which targets disease-specific T cells in vivo without broad immune modulation. The company’s lead autoimmune candidate is CUE-401, a bifunctional IL-2 and TGF-B program that is advancing toward Phase 1 development to regulate inflammation and drive Treg-mediated tolerance.
Cue Biopharma, Inc. was formerly known as Imagen Biopharma, Inc. and changed its name to Cue Biopharma, Inc. in October 2016. The company was incorporated in 2014 and is headquartered in Boston, Massachusetts.
Cue Biopharma, Inc. trades under the symbol CUE. The current price is $35.35 per share. The stock has a market cap of $148.48M and is ranked 4011 by market capitalization.
The forecasted price path shows a near-term neutral stance in 2026–2028, with a transition to bullish momentum in 2029 and a continued rise into the 2030s and beyond. The model’s average price is projected to move from the near-term level toward substantially higher levels in the long term, with notable increases in the 2030s and 2040s.
A major floor 85.6% below — a decisive break under it would weaken the trend.
The nearest floor, 40.5% below — buyers have tended to step in here.
Price is pressing into resistance (0.0% away) — a breakout level to watch.
A major ceiling 27.0% above — clearing it would confirm fresh momentum.
Key CUE support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of CUE market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $34.90 | Buy | $34.81 | Buy |
| MA 10 | $31.85 | Buy | $32.70 | Buy |
| MA 20 | $29.21 | Buy | $30.41 | Buy |
| MA 50 | $27.30 | Buy | $26.35 | Buy |
| MA 100 | $18.93 | Buy | $22.29 | Buy |
| MA 200 | $17.53 | Buy | $20.61 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 66.15 | Neutral |
| Stoch RSI (14) | 100.00 | Sell |
| CCI (20) | 150.34 | Buy |
| Williams %R (14) | 0.00 | Info |
| MACD (12,26,9) | 0.82 | Buy |
| ROC (12) | 36.73 | Buy |
| Bollinger %B (20,2) | 0.99 | Neutral |
| Stochastic %K (14) | 100.00 | Sell |
| TRIX (15) | 0.92 | Buy |
| Awesome (5,34) | 7.35 | Buy |
| Ultimate (7,14,28) | 69.29 | Neutral |
| Momentum (10) | 11.24 | Buy |
| Aroon Osc (25) | 64.00 | Buy |
| Hull MA (9) | 37.53 | Sell |
| ADX (14) | 16.15 | Neutral |
| ATR (14) | 1.78 | Info |
Sentiment: BULLISH. RSI14: 60.0. SMA50: $26.44. SMA200: $17.37. Support: $20.03. Resistance: $35.35. The 30-day range is $21.64 to $57.74.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $5.31 | $36.78 | $47.00 | 0% | Neutral | |
| $25.00 | $34.46 | $51.37 | -6% | Neutral | |
| $25.34 | $37.12 | $58.96 | +1% | Neutral | |
| $30.20 | $46.61 | $77.71 | +27% | Bullish | |
| $35.67 | $57.70 | $100.15 | +57% | Bullish | |
| $41.19 | $69.64 | $125.12 | +89% | Bullish | |
| $41.09 | $72.46 | $134.22 | +97% | Bullish | |
| $36.13 | $66.36 | $126.35 | +80% | Bullish | |
| $36.64 | $69.99 | $136.63 | +90% | Bullish | |
| $34.24 | $67.99 | $135.81 | +85% | Bullish | |
| $55.70 | $123.77 | $271.71 | +237% | Bullish | |
| $125.67 | $279.26 | $642.30 | +659% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $5.31 | $36.78 | $47.11 | +0.00% |
| August 2026 | $31.28 | $37.90 | $47.84 | +3.04% |
| September 2026 | $30.16 | $37.07 | $47.77 | -2.20% |
| October 2026 | $30.93 | $38.48 | $50.45 | +3.81% |
| November 2026 | $30.24 | $38.01 | $50.56 | -1.22% |
| December 2026 | $27.48 | $34.88 | $47.00 | -8.24% |
Click any year to see its month-by-month CUE forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect CUE to range from $5.31 to $47.00 through 2026. The $36.78 average target implies a 0% move from current prices. Price action looks broadly range-bound.
The CUE price prediction for 2027 points to an average of $34.46 (low $25.00, high $51.37) — a potential decline of -6% on today's $36.78. A consolidation phase looks the most probable path here.
In 2028, CUE is projected to trade between $25.34 and $58.96, averaging $37.12 — a potential gain of +1% from today's $36.78. That is up +8% on the projected 2027 average. Price action looks broadly range-bound.
Cue Biopharma, Inc.'s 2029 outlook centres on $46.61, within a $30.20 to $77.71 range. That is up +26% on the projected 2028 average. That marks a +27% change versus current levels. Buyers look set to stay in control over this stretch.
By 2030, CUE could reach as high as $100.15, with a base case around $57.70 and support toward $35.67 — roughly +57% from $36.78. Momentum favours further upside here.
Expect CUE to range from $41.19 to $125.12 through 2031. The $69.64 average target implies a +89% move from current prices. That is up +21% on the projected 2030 average. Buyers look set to stay in control over this stretch.
The CUE price prediction for 2032 points to an average of $72.46 (low $41.09, high $134.22) — a potential gain of +97% on today's $36.78. Momentum favours further upside here.
In 2033, CUE is projected to trade between $36.13 and $126.35, averaging $66.36 — a potential gain of +80% from today's $36.78. That is -8% versus the projected 2032 average. Buyers look set to stay in control over this stretch.
Cue Biopharma, Inc.'s 2034 outlook centres on $69.99, within a $36.64 to $136.63 range. That is up +5% on the projected 2033 average. That marks a +90% change versus current levels. Momentum favours further upside here.
By 2035, CUE could reach as high as $135.81, with a base case around $67.99 and support toward $34.24 — roughly +85% from $36.78. Buyers look set to stay in control over this stretch.
Expect CUE to range from $55.70 to $271.71 through 2040. The $123.77 average target implies a +237% move from current prices. That is up +82% on the projected 2035 average. Momentum favours further upside here.
The CUE price prediction for 2050 points to an average of $279.26 (low $125.67, high $642.30) — a potential gain of +659% on today's $36.78. Buyers look set to stay in control over this stretch.
Investing $1,000 in CUE today (≈ 27.18869 CUE) could be worth
$7,592.7
+$6,592.7 (+659%) by 2050 · US Dollar
Based on the average projected CUE price of $279.26 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in CUEwould be worth at today's price.
$1,000 invested in CUE on Jul 10, 2025 (≈ 41.876048 CUE) would be worth
$1,540.2
+$540.2 (+54.0%) today · 1.54× · US Dollar
Based on a CUE entry price of $23.88 vs. today's $36.78.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $28.26 | $1,301.49 | +30.1% |
| 1 month ago | $27.86 | $1,320.17 | +32.0% |
| 3 months ago | $15.06 | $2,442.23 | +144.2% |
| 6 months ago | $10.35 | $3,553.62 | +255.4% |
| 1 year ago | $23.88 | $1,540.2 | +54.0% |
| All time (5.0y) ago | $331.5 | $110.95 | -88.9% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our CUE forecast.
Our base-case forecast reaches $74.00 around 2040.
Implied market cap at $74.00: $310.83M
The multi-year forecast shows an upward trajectory in average price, with 2029 avg $42.90 and 2030 avg $53.36, followed by significant gains in later years to 2040 avg $111.34 and 2050 avg $246.99. ROI figures align with this trajectory: 2029 ROI 21.4, 2030 ROI 50.9, 2040 ROI 215, and 2050 ROI 598.7.
Sentiment in the forecast is bullish for 2029 onward (including 2030, 2040 and 2050), while 2026–2028 are neutral. The forecast also shows substantial upside potential, with 2031 max $115.47 and 2032 max $123.75, and a 2050 max of $568.08. These are estimates, not guarantees, and depend on factors that can affect clinical development and regulatory outcomes.
The annualized volatility is 100%, underscoring the potential for wide price swings.
Tap a question to reveal the answer.
2030 - Avg $53.36; Min $32.97; Max $92.63; ROI 50.9; Sentiment BULLISH.
Near term (2026–2028) shows Neutral forecasts with averages near current levels, then a Bullish outlook from 2029 onward (e.g., 2029 Avg $42.90; 2030 Avg $53.36). ROI figures rise in later years, but these are estimates, not guarantees.
Yes. The forecast shows higher-year max values, including 2031 Max $115.47 and 2032 Max $123.75, indicating crossing $100 in those years.
Sentiment BULLISH. RSI14 60. SMA50 $26.44. SMA200 $17.37. Support $20.03. Resistance $35.35. 30-day range $21.64-$57.74.
Current price is $35.35. Market cap is $148.48M. Rank is 4011.
Cue Biopharma, Inc. Community Discussion
0Share your Cue Biopharma, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.